Level D· Scientific groundwork from lab and animal studiesAnimal StudyPubMed

Alternatively activated M2 macrophages improve autologous Fat Graft survival in a mouse model through induction of angiogenesis.

Phipps KD., Gebremeskel S., Gillis J., Hong P., Johnston B., Bezuhly M.

Animal Study, published in Plast Reconstr Surg (2015) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Plast Reconstr Surg (2015)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
25539302
DOI
10.1097/PRS.0000000000000793
Citations
59

Abstract (original English)

Variability in graft retention with subsequent undercorrection remains a significant limitation of autologous fat grafting. The authors evaluated whether graft retention in a mouse model could be improved via graft supplementation with alternatively activated M2 macrophages, cells known to play a critical role in tissue repair. Grafts from C57BL/6 mouse inguinal fat pads were supplemented with M2 macrophages generated by intraperitoneal Brewer's thioglycollate injection and in vitro culture. Grafts with saline or M2 macrophages were injected under recipient mouse scalps and assessed by serial micro-computed tomographic analysis. Explanted grafts underwent immunohistochemical and flow cytometric analyses. M2 culture supernatants were added to stromal vascular fraction adipose-derived stem cells to assess adipogenic gene expression induction. One month after graft injection, no significant difference was noted between M2 macrophage-supplemented (105 ± 7.0 mm) and control graft volumes (72 ± 22 mm). By 3 months after injection, M2 macrophage-supplemented grafts remained stable, whereas controls experienced further volume loss (103 ± 8 mm versus 39.4 ± 15 mm; p = 0.015). Presence of macrophages in supplemented grafts was confirmed by flow cytometry. M2 macrophage-supplemented grafts exhibited a 157 percent increase in vascular density compared with controls (p < 0.05). Induction of

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
Adipose TissueAnimalsAutograftsGraft SurvivalMacrophagesMaleMiceMice, Inbred C57BLModels, AnimalNeovascularization, Physiologic

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.